AG˹ٷ

STOCK TITAN

[Form 4] Bank of Marin Bancorp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Hyster-Yale, Inc. (HY) � Form 4 Insider Transaction

Director James Bemowski reported the award of 948 Class A common shares on 07/01/2025 under the company’s Non-Employee Directors� Equity Compensation Plan. The transaction was coded “A� (award) at a price of $0.00, indicating an equity grant rather than an open-market purchase. Following the award, Bemowski’s direct beneficial ownership rises to 17,720 shares, a 5.6 % increase from his prior position of 16,772 shares. No derivative securities were involved and no dispositions were reported. While the absolute share count is modest relative to Hyster-Yale’s total outstanding shares, the additional ownership marginally strengthens director-shareholder alignment.

Hyster-Yale, Inc. (HY) � Transazione Insider Modulo 4

Il direttore James Bemowski ha segnalato l’assegnazione di 948 azioni ordinarie di Classe A il 01/07/2025 nell’ambito del Piano di Compensazione Azionaria per Direttori Non Dipendenti della società. La transazione è stata codificata come “A� (assegnazione) a un prezzo di $0,00, indicando una concessione azionaria e non un acquisto sul mercato aperto. A seguito dell’assegnazione, la proprietà diretta di Bemowski sale a 17.720 azioni, con un aumento del 5,6 % rispetto alla posizione precedente di 16.772 azioni. Non sono stati coinvolti titoli derivati né segnalate cessioni. Sebbene il numero assoluto di azioni sia modesto rispetto al totale delle azioni in circolazione di Hyster-Yale, questa maggiorazione rafforza marginalmente l’allineamento tra direttore e azionisti.

Hyster-Yale, Inc. (HY) � Transacción Interna Formulario 4

El director James Bemowski informó la concesión de 948 acciones ordinarias Clase A el 01/07/2025 bajo el Plan de Compensación en Acciones para Directores No Empleados de la compañía. La transacción fue codificada como “A� (concesión) a un precio de $0.00, lo que indica una asignación de acciones en lugar de una compra en el mercado abierto. Tras la concesión, la propiedad directa de Bemowski aumenta a 17,720 acciones, un incremento del 5,6 % respecto a su posición anterior de 16,772 acciones. No se involucraron valores derivados ni se reportaron disposiciones. Aunque el número absoluto de acciones es modesto en relación con el total de acciones en circulación de Hyster-Yale, esta propiedad adicional fortalece marginalmente la alineación entre director y accionistas.

Hyster-Yale, Inc. (HY) � Form 4 내부� 거래

이사 James Bemowski� 2025� 7� 1� 회사� 비임� 이사 주식 보상 계획� 따라 948� 클래� A 보통� 수여� 보고했습니다. 거래� $0.00 가격의 “A�(수여)� 코드화되� 공개 시장 구매가 아닌 주식 부여임� 나타냅니�. 수여 � Bemowski� 직접 보유 주식은 17,720�� 증가하여 이전 16,772주에� 5.6% 상승했습니다. 파생 증권은 포함되지 않았으며 처분� 보고되지 않았습니�. 절대 주식 수는 Hyster-Yale� � 발행 주식 대� 적지�, 추가 보유� 이사와 주주 간의 정렬� 다소 강화합니�.

Hyster-Yale, Inc. (HY) � Transaction d’initié Formulaire 4

Le directeur James Bemowski a déclaré l’attribution de 948 actions ordinaires de classe A le 01/07/2025 dans le cadre du Plan de rémunération en actions pour administrateurs non salariés de la société. La transaction a été codée « A » (attribution) à un prix de 0,00 $, indiquant une attribution d’actions plutôt qu’un achat sur le marché ouvert. Suite à cette attribution, la détention directe de Bemowski passe à 17 720 actions, soit une augmentation de 5,6 % par rapport à sa position précédente de 16 772 actions. Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée. Bien que le nombre absolu d’actions soit modeste par rapport au nombre total d’actions en circulation de Hyster-Yale, cette augmentation renforce légèrement l’alignement entre le directeur et les actionnaires.

Hyster-Yale, Inc. (HY) � Form 4 Insider-Transaktion

Direktor James Bemowski meldete die Zuteilung von 948 Class A Stammaktien am 01.07.2025 im Rahmen des Aktienvergütungsplans für nicht angestellte Direktoren des Unternehmens. Die Transaktion wurde als „A� (Zuteilung) zu einem Preis von 0,00 $ codiert, was auf eine Aktienzuteilung und keinen Kauf am offenen Markt hinweist. Nach der Zuteilung steigt Bemowskis direkte wirtschaftliche Beteiligung auf 17.720 Aktien, eine Steigerung von 5,6 % gegenüber seiner vorherigen Position von 16.772 Aktien. Es waren keine Derivate beteiligt und keine Veräußerungen wurden gemeldet. Obwohl die absolute Aktienzahl im Verhältnis zu den ausstehenden Aktien von Hyster-Yale gering ist, stärkt die zusätzliche Beteiligung die Ausrichtung zwischen Direktor und Aktionären geringfügig.

Positive
  • Director ownership increases by 5.6 %, modestly improving board-shareholder alignment.
  • Transaction is an equity award at $0 cost, indicating compensation structure that ties remuneration to share performance.
Negative
  • None.

Insights

TL;DR � Small equity grant; neutral valuation impact, modestly positive governance signal.

The 948-share award represents an incremental stake worth roughly US$30-40k (assuming HY trades in the low-$30 range). That is immaterial to enterprise value and unlikely to influence earnings or cash flow forecasts. Nevertheless, insiders accumulating—rather than selling—shares is generally viewed as a favorable governance indicator because it aligns board incentives with shareholder value. No purchase on the open market means no new cash outlay, limiting read-through on valuation sentiment. Overall impact: neutral to slightly positive.

TL;DR � Routine director compensation; maintains compliance and improves alignment.

This award stems from the approved Non-Employee Directors� Equity Compensation Plan, demonstrating adherence to disclosed compensation policies. By accepting equity instead of cash, the director deepens financial exposure to company performance, a governance best practice. Because it is a scheduled grant, it does not signal unique insider knowledge. No red flags appear regarding disclosure or timing. Investor impact is minimal but directionally positive.

Hyster-Yale, Inc. (HY) � Transazione Insider Modulo 4

Il direttore James Bemowski ha segnalato l’assegnazione di 948 azioni ordinarie di Classe A il 01/07/2025 nell’ambito del Piano di Compensazione Azionaria per Direttori Non Dipendenti della società. La transazione è stata codificata come “A� (assegnazione) a un prezzo di $0,00, indicando una concessione azionaria e non un acquisto sul mercato aperto. A seguito dell’assegnazione, la proprietà diretta di Bemowski sale a 17.720 azioni, con un aumento del 5,6 % rispetto alla posizione precedente di 16.772 azioni. Non sono stati coinvolti titoli derivati né segnalate cessioni. Sebbene il numero assoluto di azioni sia modesto rispetto al totale delle azioni in circolazione di Hyster-Yale, questa maggiorazione rafforza marginalmente l’allineamento tra direttore e azionisti.

Hyster-Yale, Inc. (HY) � Transacción Interna Formulario 4

El director James Bemowski informó la concesión de 948 acciones ordinarias Clase A el 01/07/2025 bajo el Plan de Compensación en Acciones para Directores No Empleados de la compañía. La transacción fue codificada como “A� (concesión) a un precio de $0.00, lo que indica una asignación de acciones en lugar de una compra en el mercado abierto. Tras la concesión, la propiedad directa de Bemowski aumenta a 17,720 acciones, un incremento del 5,6 % respecto a su posición anterior de 16,772 acciones. No se involucraron valores derivados ni se reportaron disposiciones. Aunque el número absoluto de acciones es modesto en relación con el total de acciones en circulación de Hyster-Yale, esta propiedad adicional fortalece marginalmente la alineación entre director y accionistas.

Hyster-Yale, Inc. (HY) � Form 4 내부� 거래

이사 James Bemowski� 2025� 7� 1� 회사� 비임� 이사 주식 보상 계획� 따라 948� 클래� A 보통� 수여� 보고했습니다. 거래� $0.00 가격의 “A�(수여)� 코드화되� 공개 시장 구매가 아닌 주식 부여임� 나타냅니�. 수여 � Bemowski� 직접 보유 주식은 17,720�� 증가하여 이전 16,772주에� 5.6% 상승했습니다. 파생 증권은 포함되지 않았으며 처분� 보고되지 않았습니�. 절대 주식 수는 Hyster-Yale� � 발행 주식 대� 적지�, 추가 보유� 이사와 주주 간의 정렬� 다소 강화합니�.

Hyster-Yale, Inc. (HY) � Transaction d’initié Formulaire 4

Le directeur James Bemowski a déclaré l’attribution de 948 actions ordinaires de classe A le 01/07/2025 dans le cadre du Plan de rémunération en actions pour administrateurs non salariés de la société. La transaction a été codée « A » (attribution) à un prix de 0,00 $, indiquant une attribution d’actions plutôt qu’un achat sur le marché ouvert. Suite à cette attribution, la détention directe de Bemowski passe à 17 720 actions, soit une augmentation de 5,6 % par rapport à sa position précédente de 16 772 actions. Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée. Bien que le nombre absolu d’actions soit modeste par rapport au nombre total d’actions en circulation de Hyster-Yale, cette augmentation renforce légèrement l’alignement entre le directeur et les actionnaires.

Hyster-Yale, Inc. (HY) � Form 4 Insider-Transaktion

Direktor James Bemowski meldete die Zuteilung von 948 Class A Stammaktien am 01.07.2025 im Rahmen des Aktienvergütungsplans für nicht angestellte Direktoren des Unternehmens. Die Transaktion wurde als „A� (Zuteilung) zu einem Preis von 0,00 $ codiert, was auf eine Aktienzuteilung und keinen Kauf am offenen Markt hinweist. Nach der Zuteilung steigt Bemowskis direkte wirtschaftliche Beteiligung auf 17.720 Aktien, eine Steigerung von 5,6 % gegenüber seiner vorherigen Position von 16.772 Aktien. Es waren keine Derivate beteiligt und keine Veräußerungen wurden gemeldet. Obwohl die absolute Aktienzahl im Verhältnis zu den ausstehenden Aktien von Hyster-Yale gering ist, stärkt die zusätzliche Beteiligung die Ausrichtung zwischen Direktor und Aktionären geringfügig.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HALE JAMES C III

(Last) (First) (Middle)
504 REDWOOD BLVD., SUITE 100

(Street)
NOVATO CA 94947

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bank of Marin Bancorp [ BMRC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 J(1) 992 A $24.05 17,079 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $34.6 01/03/2017 01/03/2027 Common Stock 2,378 2,378 D
Stock Options (Right to Buy) $31.23 07/03/2017 07/03/2027 Common Stock 2,950 2,950 D
Stock Options (Right to Buy) $33.9 01/02/2018 01/02/2028 Common Stock 2,546 2,546 D
Stock Options (Right to Buy) $40.7 07/02/2018 07/02/2028 Common Stock 1,918 1,918 D
Stock Options (Right to Buy) $41.35 01/02/2019 01/02/2029 Common Stock 1,976 1,976 D
Stock Options (Right to Buy) $41.8 07/01/2019 07/01/2029 Common Stock 2,154 2,154 D
Stock Options (Right to Buy) $44.85 01/02/2020 01/02/2030 Common Stock 2,038 2,038 D
Stock Options (Right to Buy) $32.2 07/01/2020 07/02/2030 Common Stock 2,559 2,559 D
Stock Options (Right to Buy) $34.86 01/04/2021 01/04/2031 Common Stock 2,240 2,240 D
Stock Options (Right to Buy) $32.41 07/01/2021 07/01/2031 Common Stock 2,479 2,479 D
Stock Options (Right to Buy) $32.55 07/01/2022 07/01/2032 Common Stock 2,410 2,410 D
Stock Options (Right to Buy) $32.54 01/03/2023 01/03/2023 Common Stock 2,317 2,317 D
Explanation of Responses:
1. Shares received in payment of Director fee
/s/ Krissy Meyer, Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Hyster-Yale (HY) shares did Director James Bemowski receive?

948 Class A common shares were awarded on 07/01/2025.

What is Bemowski’s total beneficial ownership after the award?

He now directly owns 17,720 shares of HY.

Was the transaction an open-market purchase?

No. It was coded "A" for an award under the Non-Employee Directors� Equity Compensation Plan.

Did the filing report any sales or derivative activity?

No sales or derivative securities were reported in this Form 4.

Does the award impact Hyster-Yale’s earnings or cash flow?

The share grant is immaterial to company finances and has no direct earnings impact.
Bank Marin Bancorp

NASDAQ:BMRC

BMRC Rankings

BMRC Latest News

BMRC Latest SEC Filings

BMRC Stock Data

368.10M
14.56M
9.62%
59.11%
3.52%
Banks - Regional
State Commercial Banks
United States
NOVATO